US2018148704A1PendingUtilityA1

Polypeptides having beta-mannanase activity and methods of use

Assignee: DANISCO US INCPriority: Dec 7, 2012Filed: Jan 16, 2018Published: May 31, 2018
Est. expiryDec 7, 2032(~6.4 yrs left)· nominal 20-yr term from priority
C12P 19/14C12Y 302/01025C12N 9/2491C12P 19/02C12Y 302/01078C12N 9/2494
50
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present compositions and methods relate to a beta-mannanase from Bacillus hemicellulosilyticus , polynucleotides encoding the beta-mannanase, and methods of make and/or use thereof. Formulations containing the beta-mannanase are suitable for use in hydrolyzing lignocellulosic biomass substrates, especially those comprising a measurable level of galactoglucomannan (GGM) and/or glucomannan (GM).

Claims

exact text as granted — not AI-modified
We claim: 
     
         1 . An enzyme composition comprising a recombinant polypeptide comprising an amino acid sequence that is at least 70% identical to the amino acid sequence of SEQ ID NO:2 or SEQ ID NO:3, wherein the polypeptide has beta-mannanase activity, and one or more cellulases. 
     
     
         2 . The enzyme composition of  claim 1 , wherein the recombinant polypeptide improves the hydrolysis performance of the enzyme composition when the recombinant polypeptide constitutes up to 20 wt. % of the enzyme composition, wherein the improved hydrolysis performance comprises:
 (a) an increased % glucan conversion, an increased % xylan conversion, and/or an increased % glucan and % xylan conversion from a given lignocellulosic biomass substrate under the same hydrolysis conditions; or   (b) an at least about 5% faster viscosity reduction of a given lignocellulosic biomass substrate under the same hydrolysis conditions.   
     
     
         3 . The enzyme composition of  claim 1  or  2 , wherein the recombinant polypeptide has an increased beta-mannanase activity as compared to the beta-mannanase activity of ScoMan1 comprising SEQ ID NO:4. 
     
     
         4 . The enzyme composition of  claim 1  or  2 , wherein the recombinant polypeptide has an increased beta-mannanase activity as compared to the beta-mannanase activity of Bsp Man1 comprising SEQ ID NO:5. 
     
     
         5 . The enzyme composition of  claim 1  or  2 , wherein the recombinant polypeptide has an increased beta-mannanase activity as compared to the beta-mannanase activity of Msp Man2 comprising SEQ ID NO:6. 
     
     
         6 . The enzyme composition of any one of  claims 1 - 5 , wherein the recombinant polypeptide retains greater than 70% of the beta-mannanase activity when incubated at a pH range from pH 6 to pH 9. 
     
     
         7 . The enzyme composition of any one of  claims 1 - 6 , wherein the recombinant polypeptide has optimum beta-mannanase activity at a pH of about 8.0 to 9.0. 
     
     
         8 . The enzyme composition of any one of  claims 1 - 7 , wherein the recombinant polypeptide retains at least 80% or more of the beta-mannanase activity when incubated at a temperature of between 50° C. and 74° C. 
     
     
         9 . The enzyme composition of any one of  claims 1 - 8 , wherein the recombinant polypeptide has optimum beta-mannanase activity at a temperature of about 64° C. 
     
     
         10 . The enzyme composition of any one of  claims 1 - 9 , wherein the recombinant polypeptide retains at least 50% of the beta-mannanase activity when incubated for about 2 hours at a temperature of about 75° C. 
     
     
         11 . The enzyme composition of any one of  claims 1 - 10 , wherein the recombinant polypeptide retains at least 95% of the beta-mannanase activity when incubated for about 2 hours at a temperature of up to 55° C. 
     
     
         12 . The enzyme composition of any one of  claims 1 - 11 , wherein the recombinant polypeptide comprises an amino acid sequence that is at least 80% identical to the amino acid sequence of SEQ ID NO:2 or SEQ ID NO:3. 
     
     
         13 . The enzyme composition of any one of  claims 1 - 12 , wherein the recombinant polypeptide comprises an amino acid sequence that is at least 90% identical to the amino acid sequence of SEQ ID NO:2 or SEQ ID NO:3. 
     
     
         14 . The enzyme composition of any one of  claims 1 - 13 , wherein the recombinant polypeptide comprises an amino acid sequence that is at least 95% identical to the amino acid sequence of SEQ ID NO:2 or SEQ ID NO:3. 
     
     
         15 . The enzyme composition of any one of  claims 1 - 14 , wherein the one or more cellulases are selected from one or more beta-glucosidases, one or more cellobiohydrolases, and one or more endoglucanases. 
     
     
         16 . The enzyme composition of any one of  claims 1 - 15 , further comprising one or more other hemicellulases. 
     
     
         17 . The enzyme composition of  claim 16 , wherein the one or more other hemicellulases are selected from one or more other beta-mannanases, one or more one or more xylanases, one or more beta-xylosidases, and one or more L-arabinofuranosidases. 
     
     
         18 . A nucleic acid encoding the a recombinant polypeptide comprising an amino acid sequence that is at least 70% identical to SEQ ID NO:2 or to the mature sequence of SEQ ID NO:3, wherein the recombinant polypeptide has beta-mannanase activity. 
     
     
         19 . The nucleic acid of  claim 18 , wherein the recombinant polypeptide further comprises a signal peptide sequence. 
     
     
         20 . The nucleic acid of  claim 19 , wherein the signal peptide sequence is selected from any one of SEQ ID NOs:13-41. 
     
     
         21 . An expression vector comprising the nucleic acid of any one of  claims 18 - 20  in operable combination with a regulatory sequence. 
     
     
         22 . A host cell comprising the expression vector of  claim 21 . 
     
     
         23 . The host cell of  claim 22 , wherein the host cell is a bacterial cell or a fungal cell. 
     
     
         24 . A composition comprising the host cell of  claim 22  or  23  and a culture medium. 
     
     
         25 . A method of producing a beta-mannanase, comprising: culturing the host cell of  claim 22  or  23  in a culture medium, under suitable conditions to produce the beta-mannanase. 
     
     
         26 . A composition comprising the beta-mannanase produced in accordance with the method of  claim 25  in supernatant of the culture medium. 
     
     
         27 . A method for hydrolyzing a lignocellulosic biomass substrate, comprising: contacting the lignocellulosic biomass substrate with the enzyme composition of any one of  claims 1 - 17  and  26 , to yield glucose and other sugars. 
     
     
         28 . The method of  claim 27 , wherein the lignocellulosic biomass substrate comprises up to about 20 wt. %, up to about 15%, or up to about 10 wt. % of galactoglucomannan and/or glucomannan. 
     
     
         29 . A composition comprising the enzyme compositions of any one of  claims 1 - 17  and a lignocellulosic biomass substrate. 
     
     
         30 . The composition of  claim 29 , wherein the lignocellulosic biomass substrate comprises up to about 20 wt. %, or up to about 15 wt. %, or up to about 10 wt. % of galactoglucomannan and/or glucomannan.

Join the waitlist — get patent alerts

Track US2018148704A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.